STAT3 and chronic myelogenous leukemia, BCR-ABL1 positive: In addition, we demonstrated that STAT3 knockdown decreased cell proliferation and increased imatinib sensitivity in KLC2-R312W and KLC2-L523I MT cells, similar to WT cells, highlighting the pivotal role of STAT3 in mediating drug resistance in CML cells.